Antigen Presenting Cell (APC)

Antigen Presenting Cell (APC) describes a specialised immune cell that processes antigens and displays antigen fragments on its surface to activate T cells and initiate adaptive immune responses. Key APC types include dendritic cells, macrophages, and B cells, each playing a central role in immune surveillance and response coordination. By presenting antigens through major histocompatibility complex (MHC) molecules, APCs enable immune recognition of pathogens, tumours, and other foreign or abnormal biological signals.

In immunotherapy and vaccine development, antigen presenting cells are critical for determining immune response strength, specificity, and long-term memory formation. Biopharmaceutical companies design therapies that enhance APC function to improve cancer immune targeting or strengthen vaccine efficacy. Cell therapy platforms may involve ex vivo manipulation of APCs to stimulate desired immune pathways, requiring precise process control and validated functional assays. As immuno-oncology pipelines expand, understanding APC biology supports improved patient stratification, biomarker development, and rational combination strategies that maximise clinical benefit while managing immune-related safety risks.